Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06441747 |
Title | Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP) |
Recruitment | Not yet recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Australasian Gastro-Intestinal Trials Group |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Chris O'Brien Lifehouse | Camperdown | New South Wales | 2050 | Australia | Details | |
Monash Medical Centre | Clayton | New South Wales | 3168 | Australia | Details | |
Westmead Hospital | Westmead | New South Wales | 2145 | Australia | Details | |
Wollongong Hospital | Wollongong | New South Wales | 2500 | Australia | Details | |
Royal Brisbane Women's Hospital | Brisbane | Queensland | 4006 | Australia | Details | |
Princess Alexandra Hospital | Woolloongabba | Queensland | 4102 | Australia | Details | |
Flinders Medical Centre | Bedford Park | South Australia | Australia | Details | ||
Austin Health | Melbourne | Victoria | 3084 | Australia | Details | |
Western Health | Saint Albans | Victoria | 3021 | Australia | Details | |
St John of God Hospital, Subiaco | Perth | Western Australia | Australia | Details |